Synthesis of pyrazoles and isoxazoles as potent alpha sub(v) beta sub(3) receptor antagonists

We describe a series of pyrazole and isoxazole analogs as antagonists of the alpha sub(v) beta sub(3) receptor. Compounds showed low to sub-nanomolar potency against alpha sub(v) beta sub(3), as well as good selectivity against alpha sub(IIb) beta sub(3). In HT29 cells, most analogs also demonstrate...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Bioorganic & medicinal chemistry letters 2006-06, Vol.16 (12), p.3156-3161
Hauptverfasser: Penning, Thomas D, Khilevich, Albert, Chen, Barbara B, Russell, Mark A, Boys, Mark L, Wang, Yaping, Duffin, Tiffany, Engleman, VWayne, Finn, Mary Beth, Freeman, Sandra K, Hanneke, Melanie L, Keene, Jeffery L, Klover, Jon A, Nickols, GAllen, Nickols, Maureen A, Rader, Randall K, Settle, Steven L, Shannon, Kristen E, Steininger, Christina N, Westlin, Marisa M, Westlin, William F
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 3161
container_issue 12
container_start_page 3156
container_title Bioorganic & medicinal chemistry letters
container_volume 16
creator Penning, Thomas D
Khilevich, Albert
Chen, Barbara B
Russell, Mark A
Boys, Mark L
Wang, Yaping
Duffin, Tiffany
Engleman, VWayne
Finn, Mary Beth
Freeman, Sandra K
Hanneke, Melanie L
Keene, Jeffery L
Klover, Jon A
Nickols, GAllen
Nickols, Maureen A
Rader, Randall K
Settle, Steven L
Shannon, Kristen E
Steininger, Christina N
Westlin, Marisa M
Westlin, William F
description We describe a series of pyrazole and isoxazole analogs as antagonists of the alpha sub(v) beta sub(3) receptor. Compounds showed low to sub-nanomolar potency against alpha sub(v) beta sub(3), as well as good selectivity against alpha sub(IIb) beta sub(3). In HT29 cells, most analogs also demonstrated significant selectivity against alpha sub(v) beta sub(6). Several compounds showed good pharmacokinetic properties in rats, in addition to anti-angiogenic activity in a mouse corneal micropocket model. Compounds were synthesized in a straightforward manner from readily available glutarate precursors.
doi_str_mv 10.1016/j.bmcl.2006.03.045
format Article
fullrecord <record><control><sourceid>proquest</sourceid><recordid>TN_cdi_proquest_miscellaneous_17172222</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>17172222</sourcerecordid><originalsourceid>FETCH-proquest_miscellaneous_171722223</originalsourceid><addsrcrecordid>eNqNi7FuwjAURS1EJQLtD3R6U1WGmOfEhDJXRewwsCDkpI8myNhunlOVfj1IhZ273HOlc4V4VigVqmJykOWxsjJDLCTmEvW0JxKlC53mGqd9keC8wPRtrjcDMWQ-ICqNWidiuzq5WBM3DH4P4dSaP2-JwbhPaNj_3iZD8JFcBGNDbYC78vVnDCXFf87H0FJFIfr2co3my7uGIz-Kh72xTE_XHomXxcf6fZmG1n93xHF3bLgia40j3_FOzdQsuyS_WzwDAoFOdg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17172222</pqid></control><display><type>article</type><title>Synthesis of pyrazoles and isoxazoles as potent alpha sub(v) beta sub(3) receptor antagonists</title><source>Elsevier ScienceDirect Journals</source><creator>Penning, Thomas D ; Khilevich, Albert ; Chen, Barbara B ; Russell, Mark A ; Boys, Mark L ; Wang, Yaping ; Duffin, Tiffany ; Engleman, VWayne ; Finn, Mary Beth ; Freeman, Sandra K ; Hanneke, Melanie L ; Keene, Jeffery L ; Klover, Jon A ; Nickols, GAllen ; Nickols, Maureen A ; Rader, Randall K ; Settle, Steven L ; Shannon, Kristen E ; Steininger, Christina N ; Westlin, Marisa M ; Westlin, William F</creator><creatorcontrib>Penning, Thomas D ; Khilevich, Albert ; Chen, Barbara B ; Russell, Mark A ; Boys, Mark L ; Wang, Yaping ; Duffin, Tiffany ; Engleman, VWayne ; Finn, Mary Beth ; Freeman, Sandra K ; Hanneke, Melanie L ; Keene, Jeffery L ; Klover, Jon A ; Nickols, GAllen ; Nickols, Maureen A ; Rader, Randall K ; Settle, Steven L ; Shannon, Kristen E ; Steininger, Christina N ; Westlin, Marisa M ; Westlin, William F</creatorcontrib><description>We describe a series of pyrazole and isoxazole analogs as antagonists of the alpha sub(v) beta sub(3) receptor. Compounds showed low to sub-nanomolar potency against alpha sub(v) beta sub(3), as well as good selectivity against alpha sub(IIb) beta sub(3). In HT29 cells, most analogs also demonstrated significant selectivity against alpha sub(v) beta sub(6). Several compounds showed good pharmacokinetic properties in rats, in addition to anti-angiogenic activity in a mouse corneal micropocket model. Compounds were synthesized in a straightforward manner from readily available glutarate precursors.</description><identifier>ISSN: 0960-894X</identifier><identifier>EISSN: 1464-3405</identifier><identifier>DOI: 10.1016/j.bmcl.2006.03.045</identifier><language>eng</language><ispartof>Bioorganic &amp; medicinal chemistry letters, 2006-06, Vol.16 (12), p.3156-3161</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids></links><search><creatorcontrib>Penning, Thomas D</creatorcontrib><creatorcontrib>Khilevich, Albert</creatorcontrib><creatorcontrib>Chen, Barbara B</creatorcontrib><creatorcontrib>Russell, Mark A</creatorcontrib><creatorcontrib>Boys, Mark L</creatorcontrib><creatorcontrib>Wang, Yaping</creatorcontrib><creatorcontrib>Duffin, Tiffany</creatorcontrib><creatorcontrib>Engleman, VWayne</creatorcontrib><creatorcontrib>Finn, Mary Beth</creatorcontrib><creatorcontrib>Freeman, Sandra K</creatorcontrib><creatorcontrib>Hanneke, Melanie L</creatorcontrib><creatorcontrib>Keene, Jeffery L</creatorcontrib><creatorcontrib>Klover, Jon A</creatorcontrib><creatorcontrib>Nickols, GAllen</creatorcontrib><creatorcontrib>Nickols, Maureen A</creatorcontrib><creatorcontrib>Rader, Randall K</creatorcontrib><creatorcontrib>Settle, Steven L</creatorcontrib><creatorcontrib>Shannon, Kristen E</creatorcontrib><creatorcontrib>Steininger, Christina N</creatorcontrib><creatorcontrib>Westlin, Marisa M</creatorcontrib><creatorcontrib>Westlin, William F</creatorcontrib><title>Synthesis of pyrazoles and isoxazoles as potent alpha sub(v) beta sub(3) receptor antagonists</title><title>Bioorganic &amp; medicinal chemistry letters</title><description>We describe a series of pyrazole and isoxazole analogs as antagonists of the alpha sub(v) beta sub(3) receptor. Compounds showed low to sub-nanomolar potency against alpha sub(v) beta sub(3), as well as good selectivity against alpha sub(IIb) beta sub(3). In HT29 cells, most analogs also demonstrated significant selectivity against alpha sub(v) beta sub(6). Several compounds showed good pharmacokinetic properties in rats, in addition to anti-angiogenic activity in a mouse corneal micropocket model. Compounds were synthesized in a straightforward manner from readily available glutarate precursors.</description><issn>0960-894X</issn><issn>1464-3405</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><recordid>eNqNi7FuwjAURS1EJQLtD3R6U1WGmOfEhDJXRewwsCDkpI8myNhunlOVfj1IhZ273HOlc4V4VigVqmJykOWxsjJDLCTmEvW0JxKlC53mGqd9keC8wPRtrjcDMWQ-ICqNWidiuzq5WBM3DH4P4dSaP2-JwbhPaNj_3iZD8JFcBGNDbYC78vVnDCXFf87H0FJFIfr2co3my7uGIz-Kh72xTE_XHomXxcf6fZmG1n93xHF3bLgia40j3_FOzdQsuyS_WzwDAoFOdg</recordid><startdate>20060601</startdate><enddate>20060601</enddate><creator>Penning, Thomas D</creator><creator>Khilevich, Albert</creator><creator>Chen, Barbara B</creator><creator>Russell, Mark A</creator><creator>Boys, Mark L</creator><creator>Wang, Yaping</creator><creator>Duffin, Tiffany</creator><creator>Engleman, VWayne</creator><creator>Finn, Mary Beth</creator><creator>Freeman, Sandra K</creator><creator>Hanneke, Melanie L</creator><creator>Keene, Jeffery L</creator><creator>Klover, Jon A</creator><creator>Nickols, GAllen</creator><creator>Nickols, Maureen A</creator><creator>Rader, Randall K</creator><creator>Settle, Steven L</creator><creator>Shannon, Kristen E</creator><creator>Steininger, Christina N</creator><creator>Westlin, Marisa M</creator><creator>Westlin, William F</creator><scope>7QO</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope></search><sort><creationdate>20060601</creationdate><title>Synthesis of pyrazoles and isoxazoles as potent alpha sub(v) beta sub(3) receptor antagonists</title><author>Penning, Thomas D ; Khilevich, Albert ; Chen, Barbara B ; Russell, Mark A ; Boys, Mark L ; Wang, Yaping ; Duffin, Tiffany ; Engleman, VWayne ; Finn, Mary Beth ; Freeman, Sandra K ; Hanneke, Melanie L ; Keene, Jeffery L ; Klover, Jon A ; Nickols, GAllen ; Nickols, Maureen A ; Rader, Randall K ; Settle, Steven L ; Shannon, Kristen E ; Steininger, Christina N ; Westlin, Marisa M ; Westlin, William F</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-proquest_miscellaneous_171722223</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Penning, Thomas D</creatorcontrib><creatorcontrib>Khilevich, Albert</creatorcontrib><creatorcontrib>Chen, Barbara B</creatorcontrib><creatorcontrib>Russell, Mark A</creatorcontrib><creatorcontrib>Boys, Mark L</creatorcontrib><creatorcontrib>Wang, Yaping</creatorcontrib><creatorcontrib>Duffin, Tiffany</creatorcontrib><creatorcontrib>Engleman, VWayne</creatorcontrib><creatorcontrib>Finn, Mary Beth</creatorcontrib><creatorcontrib>Freeman, Sandra K</creatorcontrib><creatorcontrib>Hanneke, Melanie L</creatorcontrib><creatorcontrib>Keene, Jeffery L</creatorcontrib><creatorcontrib>Klover, Jon A</creatorcontrib><creatorcontrib>Nickols, GAllen</creatorcontrib><creatorcontrib>Nickols, Maureen A</creatorcontrib><creatorcontrib>Rader, Randall K</creatorcontrib><creatorcontrib>Settle, Steven L</creatorcontrib><creatorcontrib>Shannon, Kristen E</creatorcontrib><creatorcontrib>Steininger, Christina N</creatorcontrib><creatorcontrib>Westlin, Marisa M</creatorcontrib><creatorcontrib>Westlin, William F</creatorcontrib><collection>Biotechnology Research Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><jtitle>Bioorganic &amp; medicinal chemistry letters</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Penning, Thomas D</au><au>Khilevich, Albert</au><au>Chen, Barbara B</au><au>Russell, Mark A</au><au>Boys, Mark L</au><au>Wang, Yaping</au><au>Duffin, Tiffany</au><au>Engleman, VWayne</au><au>Finn, Mary Beth</au><au>Freeman, Sandra K</au><au>Hanneke, Melanie L</au><au>Keene, Jeffery L</au><au>Klover, Jon A</au><au>Nickols, GAllen</au><au>Nickols, Maureen A</au><au>Rader, Randall K</au><au>Settle, Steven L</au><au>Shannon, Kristen E</au><au>Steininger, Christina N</au><au>Westlin, Marisa M</au><au>Westlin, William F</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Synthesis of pyrazoles and isoxazoles as potent alpha sub(v) beta sub(3) receptor antagonists</atitle><jtitle>Bioorganic &amp; medicinal chemistry letters</jtitle><date>2006-06-01</date><risdate>2006</risdate><volume>16</volume><issue>12</issue><spage>3156</spage><epage>3161</epage><pages>3156-3161</pages><issn>0960-894X</issn><eissn>1464-3405</eissn><abstract>We describe a series of pyrazole and isoxazole analogs as antagonists of the alpha sub(v) beta sub(3) receptor. Compounds showed low to sub-nanomolar potency against alpha sub(v) beta sub(3), as well as good selectivity against alpha sub(IIb) beta sub(3). In HT29 cells, most analogs also demonstrated significant selectivity against alpha sub(v) beta sub(6). Several compounds showed good pharmacokinetic properties in rats, in addition to anti-angiogenic activity in a mouse corneal micropocket model. Compounds were synthesized in a straightforward manner from readily available glutarate precursors.</abstract><doi>10.1016/j.bmcl.2006.03.045</doi></addata></record>
fulltext fulltext
identifier ISSN: 0960-894X
ispartof Bioorganic & medicinal chemistry letters, 2006-06, Vol.16 (12), p.3156-3161
issn 0960-894X
1464-3405
language eng
recordid cdi_proquest_miscellaneous_17172222
source Elsevier ScienceDirect Journals
title Synthesis of pyrazoles and isoxazoles as potent alpha sub(v) beta sub(3) receptor antagonists
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-12T01%3A13%3A35IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Synthesis%20of%20pyrazoles%20and%20isoxazoles%20as%20potent%20alpha%20sub(v)%20beta%20sub(3)%20receptor%20antagonists&rft.jtitle=Bioorganic%20&%20medicinal%20chemistry%20letters&rft.au=Penning,%20Thomas%20D&rft.date=2006-06-01&rft.volume=16&rft.issue=12&rft.spage=3156&rft.epage=3161&rft.pages=3156-3161&rft.issn=0960-894X&rft.eissn=1464-3405&rft_id=info:doi/10.1016/j.bmcl.2006.03.045&rft_dat=%3Cproquest%3E17172222%3C/proquest%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=17172222&rft_id=info:pmid/&rfr_iscdi=true